CHOLIB 145mg / 40mg tablets medication leaflet

C10BA04 • fenofibrate + simvastatin • Cardiovascular system | Lipid modifying agents, combinations | Combinations of various lipid modifying agents

The combination of fenofibrate and simvastatin is used to treat dyslipidemia, meaning elevated levels of fats (cholesterol and triglycerides) in the blood. Fenofibrate helps lower triglycerides, while simvastatin reduces LDL cholesterol, working together to prevent cardiovascular diseases.

The medication is taken orally as prescribed by the doctor, with the dose adjusted based on blood test results and the patient's cardiovascular risk. It is important for the patient to follow a balanced diet and maintain a healthy lifestyle during treatment.

Side effects may include muscle pain, increased liver enzyme levels, digestive disorders, or, rarely, severe allergic reactions. In rare cases, serious muscle conditions such as rhabdomyolysis may occur. Any unusual symptoms should be reported to the doctor immediately.

The combination of fenofibrate and simvastatin is effective in controlling blood fat levels, but requires regular medical monitoring. Following the doctor's recommendations and being informed about possible side effects are essential for safe and effective treatment.